Defense World
30 Nov 2025, 07:56 UTC · 42w ago
Travere Therapeutics (NASDAQ:TVTX) Reaches New 52-Week High – Still a Buy?
Verdict
Headline takes no side. We score TVTX +0.60 — strongly bullish.
- Expected · TVTX
+0.60strongly bullish
−1 bearish0bullish +1More positive than 71% of ticker scores this week
- Actual
